10 min listen
E48: ADACTA - Tocilizumab or Adalimumab in MTX Intolerant Patients with RA
E48: ADACTA - Tocilizumab or Adalimumab in MTX Intolerant Patients with RA
ratings:
Length:
10 minutes
Released:
Oct 3, 2019
Format:
Podcast episode
Description
This week I revisit an old paper - the 2013 ADACTA trial that assessed tocilizumab and adalimumab for patients who cannot take or were intolerant of MTX.
Released:
Oct 3, 2019
Format:
Podcast episode
Titles in the series (87)
E7: The ALMS Trial - MMF vs CYC for Lupus Nephritis: Today we'll be discussing the ALMS trial, which pitted cellcept against cyclophosphamide. It's a good trial that has had profound influences on our practice and well worth a read. Access the paper itself here. by The Evidence Based Rheumatology Podcast